Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Perren

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|October 1, 1987
Mediastinal emphysema in marrow transplant recipientsG Hill, G Helenglass, R Powles, et al.
BMJ (Clinical Research Ed.)|September 30, 2006
Implications of ejection fraction value for trastuzumabD Schlosshan, C Dickinson, R Sapsford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
The endodermal sinus tumour and clear cell ovarian cancerM E O'Brien, T Perren, S Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferonK Pittman, T Perren, U Ward, et al.
British Journal of Cancer|October 1, 1990
The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancerJ Hardy, I Smith, G Cherryman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical recordsG Velikova, P Wright, A B Smith, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancerC J Poole, T Perren, S Gawande, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trialJ F Smyth, A Bowman, T Perren, et al.
British Journal of Cancer|February 1, 1991
Phase II trial of trimelamol in refractory ovarian cancerI R Judson, A H Calvert, M E Gore, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|October 1, 1987
Mediastinal emphysema in marrow transplant recipientsG Hill, G Helenglass, R Powles, et al.
BMJ (Clinical Research Ed.)|September 30, 2006
Implications of ejection fraction value for trastuzumabD Schlosshan, C Dickinson, R Sapsford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
The endodermal sinus tumour and clear cell ovarian cancerM E O'Brien, T Perren, S Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferonK Pittman, T Perren, U Ward, et al.
British Journal of Cancer|October 1, 1990
The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancerJ Hardy, I Smith, G Cherryman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical recordsG Velikova, P Wright, A B Smith, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancerC J Poole, T Perren, S Gawande, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trialJ F Smyth, A Bowman, T Perren, et al.
British Journal of Cancer|February 1, 1991
Phase II trial of trimelamol in refractory ovarian cancerI R Judson, A H Calvert, M E Gore, et al.
Pageof 4